Purpose
EQ-5D™ is a standardized instrument for use as a measure of health for clinical and economic appraisal.
Acronym
EQ-5D
Cost
Not Free
Cost Description
Fee involved for licensing
Diagnosis/Conditions
- Arthritis + Joint Conditions
- Pain Management
- Pulmonary Disorders
- Stroke Recovery
- Applicable to a wide range of health conditions and treatments, the EQ-5D health questionnaire provides a simple descriptive profile and a single index value for health status.
- Measures the 5 dimensions of:
1) mobility
2) self-care
3) usual activities
4) pain/discomfort
5) anxiety/depression
- Each dimension is described by 3 possible levels of problems:
1) none
2) mild to moderate
3) severe
- Respondent’s answer to different hypothetical choices are translated into a preference-based score, yielding an index score based on a scale from 0.000 (death) to 1.000 (perfect health).
- The five dimensions measuring health status can be converted to a single utility value (EQ-Index score)
Required Training
No Training
Instrument Reviewers
Initially reviewed by Sue Saliga, PT, PHSc, CEEAA and the TBI EDGE task force of the Neurology Section of the APTA in 10/2012
Updated by Rie Yoshida and Heather Anderson of the StrokEDGE II task force of the Neurology Section of the APTA in 2016.
ICF Domain
Body Structure
Body Function
Participation
Professional Association Recommendation
Recommendations for use of the instrument from the Neurology Section of the American Physical Therapy Association’s Multiple Sclerosis Taskforce (MSEDGE), Parkinson’s Taskforce (PD EDGE), Spinal Cord Injury Taskforce (PD EDGE), Stroke Taskforce (StrokEDGE), Traumatic Brain Injury Taskforce (TBI EDGE), and Vestibular Taskforce (Vestibular EDGE) are listed below. These recommendations were developed by a panel of research and clinical experts using a modified Delphi process.
For detailed information about how recommendations were made, please visit: http://www.neuropt.org/go/healthcare-professionals/neurology-section-outcome-measures-recommendations
Abbreviations: | |
HR | Highly Recommend |
R | Recommend |
LS / UR | Reasonable to use, but limited study in target group / Unable to Recommend |
NR | Not Recommended |
Recommendations for use based on acuity level of the patient:
| Acute (CVA < 2 months post) (SCI < 1 month post) (Vestibular < 6 months post) | Subacute (CVA 2 to 6 months) (SCI 3 to 6 months) | Chronic (> 6 months) |
StrokEDGE | NR | R | R |
Recommendations based on level of care in which the assessment is taken:
| Acute Care | Inpatient Rehabilitation | Skilled Nursing Facility | Outpatient Rehabilitation | Home Health |
StrokEDGE | NR | R | R | R | R |
TBI EDGE | NR | LS | NR | LS | LS |
Recommendations for use based on ambulatory status after brain injury:
| Completely Independent | Mildly dependant | Moderately Dependant | Severely Dependant |
TBI EDGE | N/A | N/A | N/A | N/A |
Recommendations for entry-level physical therapy education and use in research:
| Students should learn to administer this tool? (Y/N) | Students should be exposed to tool? (Y/N) | Appropriate for use in intervention research studies? (Y/N) | Is additional research warranted for this tool (Y/N) |
StrokEDGE | No | Yes | Yes | Not reported |
TBI EDGE | No | Yes | Yes | Not reported |
Considerations
- Translations available in over 150 languages
- Recommended by the Core Data Elements Workgroup as a supplemental measure in TBI research (Wilde et al, 2010)
- In TBI, the instrument has been used in some outcome studies with good success
EuroQOL translations:
Other languages available at https://euroqol.org/eq-5d-instruments/eq-5d-5l-available-modes-of-administration/self-complete-on-paper/
These translations, and links to them, are subject to the Terms and Conditions of Use of the Rehab Measures Database. RIC is not responsible for and does not endorse the content, products or services of any third-party website, and does not make any representations regarding its quality, content or accuracy. If you would like to contribute a language translation to the RMD, please contact us at rehabmeasures@ric.org.
Do you see an error or have a suggestion for this instrument summary? Please e-mail us!